Rbf Capital, LLC Keros Therapeutics, Inc. Transaction History
Rbf Capital, LLC
- $2.16 Billion
- Q3 2025
A detailed history of Rbf Capital, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Rbf Capital, LLC holds 150,000 shares of KROS stock, worth $2.59 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
150,000
Previous 150,000
-0.0%
Holding current value
$2.59 Million
Previous $2 Million
18.53%
% of portfolio
0.11%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
169Shares Held
35.4MCall Options Held
574KPut Options Held
325K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$93 Million8.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.72MShares$46.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.71MShares$46.7 Million3.92% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.19MShares$37.8 Million10.27% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...